Pharmacists step in to boost blood thinner adherence in atrial fibrillation patients
NCT ID NCT07159399
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether one-on-one education from a trained pharmacist can help people with atrial fibrillation take their blood thinners (DOACs) as prescribed. About 400 patients will either receive this extra support or usual care. The goal is to see if the education improves medication adherence and reduces stroke risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pharmacist-led education program
- What this could lead to
- If successful, this could show that simple pharmacist education helps patients take their blood thinners more consistently, reducing stroke risk.
- What could go wrong
- This is a behavioral study, not a drug trial. Results depend on patient engagement and may not apply to all populations. The benefit may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
Taipei, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone alert replace daily blood thinners for AF?
- Blood fat clues could flag hidden heart rhythm risk
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Smartphone light sensor may spot when an irregular heartbeat fixes itself
- Can a Wrist-Worn sensor outsmart atrial fibrillation?